Down syndrome preleukemia and leukemia. by Maloney, K, Taub, J, Ravindranath, Y, Roberts, I, Vyas, P

Activating CSF2RB Mutations Contribute to the Leukemic Transformation from TAM to ML-DS by Labuhn, M, Perkins, K, El Kathib, M, Taub, J, Heckl, D, Vyas, P, Klusmann, J

Modelling the progression of a preleukemic stage to overt leukemia in children with down syndrome by Labuhn, M, Perkins, K, Papaemmanuil, E, Garnett, C, Matzk, S, Amstislavskiy, V, Metzner, M, Kennedy, A, Scheer, C, Yoshida, K, Schwarzer, A, Crispino, J, Taub, J, Weiss, M, Ito, E, Ogawa, S, Reinhardt, D, Yaspo, M, Campbell, P, Heckl, D, Klusmann, J, Vyas, P

Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome by Labuhn, M, Perkins, K, Matzk, S, Varghese, L, Garnett, C, Papaemmanuil, E, Metzner, M, Kennedy, A, Amstislavskiy, V, Risch, T, Bhayadia, R, Samulowski, D, Hernandez, D, Stoilova, B, Iotchkova, V, Oppermann, U, Scheer, C, Yoshida, K, Schwarzer, A, Taub, J, Crispino, J, Weiss, M, Hayashi, A, Taga, T, Ito, E, Ogawa, S, Reinhardt, D, Yaspo, M, Campbell, P, Roberts, I, Constantinescu, S, Vyas, P, Heckl, D, Klusmann, J